(Q83640566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

T L Lasho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

A Tefferi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

C Finke

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

A Pardanani

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

18 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1056-1058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415853%20AND%20SRC:MED&resulttype=core&format=json

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.45

7 January 2021

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.45

7 January 2021

LNK mutations in JAK2 mutation-negative erythrocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.45

7 January 2021

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.45

7 January 2021

Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.45

7 January 2021

JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.45

7 January 2021